Skip to content

Author

Hailah M. Almohaimeed

We have 5 of 115 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Immunomodulatory, Antioxidant, and Growth-Promoting Effects of Hylocereus undatus Peel Powder in Pacific White Shrimp (Litopenaeus vannamei).

Shrimp aquaculture is a primary supplier of high-quality aquatic protein worldwide. Incorporating natural feed additives can strengthen health and disease resilience in cultured species. This study evaluated the dietary effects of Hylocereus undatus (dragon fruit, HU) peel powder on growth performance, metabolic profil...

R. T. Mathew, Mohamed L. Ashour, M. Haroun et al. · 0 citations
#gene editing Review Sep 2026

Microbiome–Tumor–Host Interactions in Cancer Therapy: From Chemoresistance Mechanisms to Engineered Living Medicines

This review synthesizes recent advances in pharmaco‐microbiomics, reframing cancer treatment in a hologenetic context, with host, tumor and microbiome acting as a tripartite entity, and establishes microbiome as a predictor and therapeutic target in precision medicine.

Hailah M. Almohaimeed, Aniruddha Chatterjee, Sayani Ghosh et al. · 0 citations
Review Open access Jul 2026

Exosome‐Mediated Delivery of PROTACs for Targeted Protein Degradation in Cancer, Neurodegenerative, Infectious, and Inflammatory Diseases

This review traces the evolution of PROTAC technology, delineates the challenges of conventional delivery, and evaluates the rationale for exosomal encapsulation, including cargo protection, intracellular trafficking, endosomal escape, and release kinetics and outlines future directions for exosome‐mediated targeted pr...

S. Ghosh, R. Banerjee, Hailah M. Almohaimeed et al. · 0 citations
Review Aug 2026

Synthetic biology strategies for engineering microbial therapeutics in metabolic diseases and cancer.

This review highlights chassis selection, circuit architectures, applications for metabolic diseases and cancer, metabolic bottlenecks, and future directions for precision microbial therapeutics for metabolic disorders and oncology.

B. Onoja, S. Agada, Waheeb S. Aggad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.